201 related articles for article (PubMed ID: 9733054)
41. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with non‑small cell lung cancer: A comparative study.
Xu Q; Shi NJ; Zhang H; Zhu YM
Mol Med Rep; 2017 Oct; 16(4):4445-4454. PubMed ID: 28765974
[TBL] [Abstract][Full Text] [Related]
42. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure.
Tornatore KM; Venuto RC; Logue G; Davis PJ
J Med; 1998; 29(3-4):159-83. PubMed ID: 9865456
[TBL] [Abstract][Full Text] [Related]
43. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
[TBL] [Abstract][Full Text] [Related]
44. Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus.
Westerterp M; Boermeester MA; Omloo JM; Hulshof MC; Vervenne WL; Lutter R; Out TA; van Lanschot JJ
Cancer Immunol Immunother; 2008 Dec; 57(12):1837-47. PubMed ID: 18398607
[TBL] [Abstract][Full Text] [Related]
45. Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.
Bosly A; Guillaume T; Brice P; Humblet Y; Staquet P; Doyen C; Chatelain B; Franks CR; Gisselbrecht C; Symann M
Exp Hematol; 1992 Sep; 20(8):962-8. PubMed ID: 1354620
[TBL] [Abstract][Full Text] [Related]
46. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
[TBL] [Abstract][Full Text] [Related]
47. [Lymphocyte populations and subpopulations in peripheral blood of pregnant women with pre-eclampsia].
Dimitrakova-Dzhambazova E; Milchev N; Pavlov P; Dimitrakov D
Akush Ginekol (Sofiia); 2005; 44(1):40-4. PubMed ID: 15853011
[TBL] [Abstract][Full Text] [Related]
48. Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases.
Komschlies KL; Gregorio TA; Gruys ME; Back TC; Faltynek CR; Wiltrout RH
J Immunol; 1994 Jun; 152(12):5776-84. PubMed ID: 8207207
[TBL] [Abstract][Full Text] [Related]
49. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
Laso FJ; Madruga JI; López A; Ciudad J; Alvarez-Mon M; San Miguel J; Orfao A
Alcohol Clin Exp Res; 1997 Jun; 21(4):672-6. PubMed ID: 9194923
[TBL] [Abstract][Full Text] [Related]
50. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
[TBL] [Abstract][Full Text] [Related]
51. Circulating Tumor Cells Were Associated with the Number of T Lymphocyte Subsets and NK Cells in Peripheral Blood in Advanced Non-Small-Cell Lung Cancer.
Ye L; Zhang F; Li H; Yang L; Lv T; Gu W; Song Y
Dis Markers; 2017; 2017():5727815. PubMed ID: 29434410
[TBL] [Abstract][Full Text] [Related]
52. The effect of total lymphoid irradiation and low-dose steroids on T lymphocyte populations in multiple sclerosis: correlation with clinical and MRI status.
Rohowsky-Kochan C; Molinaro D; Devereux C; Troiano R; Bansil S; Zito G; Wolansky L; Jotkowitz A; Denny T; Oleske J; Dowling P; Cook SD
J Neurol Sci; 1997 Nov; 152(2):182-92. PubMed ID: 9415540
[TBL] [Abstract][Full Text] [Related]
53. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
54. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
55. Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
Zheng Y; Shi A; Wang W; Yu H; Yu R; Li D; Xu B; Ma H; You J; Zhao D; Jiang L; Geng J; Zhu G
Clin Lung Cancer; 2018 Jul; 19(4):e399-e404. PubMed ID: 29519614
[TBL] [Abstract][Full Text] [Related]
56. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
57. Changes in leukocyte subpopulations following total hip replacement surgery. Effects of high doses of corticosteroids.
Høgevold HE; Lyberg T; Reikerås O
Scand J Clin Lab Invest; 1991 Sep; 51(5):443-51. PubMed ID: 1947729
[TBL] [Abstract][Full Text] [Related]
58. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
[TBL] [Abstract][Full Text] [Related]
59. A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma.
Ratto GB; Zino P; Mirabelli S; Minuti P; Aquilina R; Fantino G; Spessa E; Ponte M; Bruzzi P; Melioli G
Cancer; 1996 Jul; 78(2):244-51. PubMed ID: 8673999
[TBL] [Abstract][Full Text] [Related]
60. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
